Article
Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
International journal of chronic obstructive pulmonary disease - 1 Jan 2017
Dilektasli Asli Gorek, Demirdogen Cetinoglu Ezgi, Uzaslan Esra, Budak Ferah, Coskun Funda, Ursavas Ahmet, Ercan Ilker, Ege Ercument
Abstract excerpt
INTRODUCTION: Chemokine (C-C motif) ligand 18 (CCL-18) has been shown to be elevated in chronic obstructive pulmonary disease (COPD) patients. This study primarily aimed to evaluate whether the serum CCL-18 level differentiates the frequent exacerbator COPD phenotype from infrequent exacerbators. The secondary aim was to investigate whether serum CCL-18 level is a risk factor for exacerbations requiring...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
